Paper3486715
Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
Salup RR and 1 other. Cancer Immunol Immunother, 1986. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease. Papers, record 3486715. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3486715
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Ascitic Fluid | Major topic |
| Interleukin-2 | Major topic |
| Kidney Neoplasms | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Animals | |
| Disease Models, Animal | |
| Doxorubicin | |
| Female | |
| Immunization, Passive | |
| Injections, Intraperitoneal | |
| Lymphocyte Activation | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01-CO-23910 | NCI NIH HHS | United States | N01CO023910 | PubMed and NIH |
Source NIH RePORTER
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6640524 | Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes. | Cancer Res | 1983 | https://conductscience.org/library/papers/6640524 | PubMed |
| 2 | 7185419 | Role of natural killer cells in control of cancer metastasis. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/7185419 | PubMed |
| 3 | 4703766 | A murine renal cell carcinoma. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4703766 | PubMed |
| 4 | 7299115 | Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. | J Immunol | 1981 | https://conductscience.org/library/papers/7299115 | PubMed |
| 5 | 3989307 | Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. | J Immunol | 1985 | https://conductscience.org/library/papers/3989307 | PubMed |
| 6 | 6164929 | Interleukin-2 augments natural killer cell activity. | Nature | 1981 | https://conductscience.org/library/papers/6164929 | PubMed |
| 7 | 6332379 | Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. | Science | 1984 | https://conductscience.org/library/papers/6332379 | PubMed |
| 8 | 6224401 | The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy. | Adv Cancer Res | 1983 | https://conductscience.org/library/papers/6224401 | PubMed |
| 9 | 4604193 | Cell-mediated immunity to tumor cells. | Adv Cancer Res | 1974 | https://conductscience.org/library/papers/4604193 | PubMed |
| 10 | 6194216 | Activation of nonspecific killer cells by interleukin 2-containing supernatants. | J Immunol | 1983 | https://conductscience.org/library/papers/6194216 | PubMed |
| 11 | 6984355 | Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6984355 | PubMed |
| 12 | 6980254 | Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. | J Exp Med | 1982 | https://conductscience.org/library/papers/6980254 | PubMed |
| 13 | 7118294 | Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. | Int J Cancer | 1982 | https://conductscience.org/library/papers/7118294 | PubMed |
| 14 | 6970768 | Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2. | J Immunol | 1981 | https://conductscience.org/library/papers/6970768 | PubMed |
| 15 | 6605805 | Supplement-induced cytotoxic cells (SICC) generated from mouse thymus or spleen cells cultured in the presence of interleukin 2 and/or polyinosinic acid. | Cell Immunol | 1983 | https://conductscience.org/library/papers/6605805 | PubMed |
| 16 | 6209054 | Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes. | Diagn Immunol | 1983 | https://conductscience.org/library/papers/6209054 | PubMed |
| 17 | 6600251 | Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells. | J Immunol | 1983 | https://conductscience.org/library/papers/6600251 | PubMed |
| 18 | 6977616 | Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. | J Exp Med | 1982 | https://conductscience.org/library/papers/6977616 | PubMed |
| 19 | 7366733 | Role of NK cells in tumour growth and metastasis in beige mice. | Nature | 1980 | https://conductscience.org/library/papers/7366733 | PubMed |
| 20 | 6984352 | Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF). | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6984352 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20041482 | Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. | Cancer | 2010 | https://conductscience.org/library/papers/20041482 | PubMed |
| 12698271 | Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. | Cancer Immunol Immunother | 2003 | https://conductscience.org/library/papers/12698271 | PubMed |
| 2676022 | Lymphokine activated killer cells. | Blut | 1989 | https://conductscience.org/library/papers/2676022 | PubMed |
| 2598180 | Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2598180 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3486715
GET https://conductscience.org/api/papers/v1/3486715/references?page=2